Life Sciences & Biomedical Research
Upcoming Events by Topic
May 15 - 17, 2017
Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)
Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.
Wednesday, May 24, 2017 | 12:00 PM - 5:00 PM
Speakers: Sean F. Brady (The Rockefeller University), Dirk Trauner (New York University)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2017, the annual year-end meeting features keynote speakers Dr Sean F. Brady and Dr Dirk Trauner.
Thursday, May 25, 2017 | 9:00 AM - 5:00 PM
Keynote Speaker: Craig Thompson (Memorial Sloan Kettering Cancer Center)
This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.
Monday, June 5, 2017 | 12:30 PM - 5:30 PM
Featuring: Jeffrey V. Ravetch (The Rockefeller University)
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine.
June 13 - 14, 2017
Keynote Speaker: Michael V. Sofroniew (David Geffen School of Medicine at UCLA)
The conference will explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries.
Monday, June 19, 2017 | 1:30 PM - 6:00 PM
Keynote Speaker: Stephen J. Elledge (Harvard Medical School)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
June 21 - 22, 2017
Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.
Tuesday, September 26, 2017 | 9:00 AM - 5:00 PM
Speakers: Nathan J. Baird (National Heart, Lung and Blood Institute, NIH), Matthew D. Disney (Scripps Research Institute), John A. Howe (Merck Research Laboratories), David H. Mathews (University of Rochester), Kevin M. Weeks (University of North Carolina at Chapel Hill), Steven C. Zimmerman (University of Illinois)
This symposium will cover approaches for targeting RNA with small and large molecules. The relevance of RNA splicing, microRNA, and RNA repeat expansions to human disease, and novel approaches for selectively modulating RNA function will be discussed.
Tuesday, October 24, 2017 | 9:00 AM - 5:00 PM
Speakers: Philip D. Gregory (bluebirdbio), Josh Lehrer (Global Blood Therapeutics), Deepa Manwani (The Children's Hospital at Montefiore, Albert Einstein College Of Medicine), Debra Pittman (Pfizer), Andreas Reik (Sangamo BioSciences), Vijay G. Sankaran (Boston Children's Hospital, Harvard Medical School), Wally Smith (Virginia Commonwealth University Medical Center), Kenneth I. Ataga (University of North Carolina at Chapel Hill)
This symposium will explore recent developments in the field including elucidation of biological mechanisms of disease and cutting-edge clinical science, while underscoring the importance of the patient experience.
Thursday, November 2, 2017 | 9:00 AM - 5:00 PM
Speakers: Marcia Haigis (Harvard Medical School), Vamsi Mootha (Harvard Medical School), Andrew Dillin (UC Berkeley), Adam Hughes (University of Utah School of Medicine), Jahar Bhattacharya (Columbia University Irving Medical Center), Jodi Nunnari (University of California, Davis), Navdeep S. Chandel (Northwestern University), J. Wade Harper (Harvard Medical School), and David J. Glass (Novartis Institutes for Biomedical Research)
This symposium will bring together cross-disciplinary researchers to explore mitochondrial biology, the role played by mitochondria in disease, and their potential as a therapeutic target.